Navigation Links
TriMed, Inc. Announces Licensing Agreement with Stryker
Date:1/11/2011

VALENCIA, Calif., Jan. 11, 2011 /PRNewswire/ -- TriMed, Inc., a developer and manufacturer of orthopaedic fixation devices based in Valencia, CA, announces that it has reached an agreement to license its "pin plate" device to Stryker, Inc. The licensing agreement covers U.S. Patent No. 5,931,839 and ends a four-year patent infringement suit. The agreement was reached in October 2010.

TriMed developed the Radial Pin Plate and Ulnar Pin Plate in 1995 for use in treating distal radius (wrist) fractures without the need for a post-surgical cast. The plates are particularly suited for stabilizing the small bone fragments of these fractures and enabling early mobilization of the injured wrist.

David Medoff, one of TriMed's owners, said, "We are pleased to have reached this agreement. TriMed is a dynamic company with the ability to create new implants for treating orthopaedic injuries and conditions. We have an unbroken record of increasing sales and profitability for the past 13 years and we will continue to concentrate on developing products for upper and lower extremities."

About TriMed, Inc.:

TriMed, Inc., a leader in advanced and innovative orthopaedic fixation systems, and specializing in small fragment fracture fixation, holds numerous patents within the field. TriMed is headquartered in Valencia, CA with offices in Sweden.


'/>"/>
SOURCE TriMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... 2016  In the next ten years, the ... systems dependent on CRTs monitors to those reliant on ... Medical monitors and will automatically sync to existing ... foreseeable benefits to this technological advancement, it also ... to be replaced in order to be LCD ...
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 2016 , ... The Wharton School of the University ... of the 2016 Wharton Business Plan Competition —as well as the Wharton ... the Committee Award for Most ‘Wow Factor,’ making them the first team in ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, ... ... integrated manufacturer and engineer of patented products, announces the Gyrociser, an exercise invention ... industry is worth $2 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
(Date:4/29/2016)... ... ... York City based oral and maxillofacial surgeon Dr. Majid Jamali is an expert ... sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients who suffer ... jaw bones. This surgery is performed to correct the alignment of the jaw. It is ...
(Date:4/29/2016)... OR (PRWEB) , ... April 29, 2016 , ... For ... dinner as the meal to miss. That was among the many new lifestyle diet ... on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence ...
Breaking Medicine News(10 mins):